MILESTONE SCIENTIFIC INC
MLSSNYSE AMERICANTrading Snapshot
- Day Range
- $0.41 – $0.42
- 52-Week Range
- $0.22 – $0.60
- Volume
- $2.32B
- Avg Volume
- $2.66B
- Shares Outstanding
- 88.4M
- Next Earnings
- Oct 31, 2026
Fundamentals Snapshot
- Annual Revenue
- $9M
- Last Q Revenue
- $3M
- P/E Ratio
- -8.6
- P/S Ratio
- 3.8x
- EPS (TTM)
- $-0.04
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +2.8%
Why Investors Own MLSS
- ✓High-growth profile — revenue up +0.1% YoY with expanding US Equity exposure.
- ✓Healthy economics — 36% gross margin and 12% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
MILESTONE SCIENTIFIC INC
MLSS
StockOtter · stockotter.spaceAbout MILESTONE SCIENTIFIC INC
Milestone Scientific Inc. is dedicated to the innovation, refinement, and global distribution of advanced diagnostic and therapeutic injection technologies and devices. These solutions cater to the medical, dental, and cosmetic industries, with a presence in the United States, China, and other international markets. The company's operations are divided into two main segments: Dental and Medical. Within its Dental division, key products include CompuDent and the STA Single Tooth Anesthesia System, both instrumental for delivering local anesthetics across all dental procedures. For broader applications, the firm offers CompuFlo, a sophisticated computer-controlled system capable of delivering drugs, anesthetics, and other medicaments comfortably and precisely, as well as aspirating bodily fluids or prior injections. Complementing this, a disposable injection handpiece provides precise tactile control during administration. In the Medical segment, Milestone Scientific introduces the CompuFlo Epidural, a computer-guided anesthesia system designed for a variety of medical applications. Additionally, their CompuMed system is utilized in numerous specialized procedures, including plastic surgery, hair restoration, colorectal surgery, podiatry, dermatology, and orthopedics, among others. Headquartered in Livingston, New Jersey, Milestone Scientific Inc. was established in 1989.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Price Target
ⓘLatest News & Updates
Milestone Scientific Highlights Building a Scalable Growth Platform for CompuFlo® Medical Business
CompuFlo Builds Momentum as Physician Adoption, Reimbursement Access, Commercial Coverage and Clinical Evidence Expand CompuFlo Builds Momentum as Physician Adoption, Reimbursement Access, Commercial Coverage and Clinica
Milestone Scientific Announces Pain and Spine Specialists and Dr. Sudhir Rao as CompuFlo® Development Partner and Advisor
ROSELAND, N.J., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery and injection technologies, today announced that Sudhir Rao, M.D.
Milestone Scientific Inc. (MLSS) Q2 2026 Earnings Call Transcript
Milestone Scientific Inc. (MLSS) Q2 2026 Earnings Call Transcript
Milestone Scientific Reports Financial Results for Second Quarter 2026
Medical Segment Revenue Grows 231% Year-Over-Year Enters Strategic Distribution Agreement to Expand CompuFlo® Access Across VA and Department of Defense Health Systems Reaffirms 2026 Outlook for Double-Digit Revenue Grow
Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call
ROSELAND, N.J., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that i
Milestone Scientific Announces Strategic Federal Distribution Partnership with Red One Medical to Expand Commercial Access for the CompuFlo® Epidural System
Partnership Expands Commercial Reach Across VA, Department of Defense and Other Federal Healthcare Systems Partnership Expands Commercial Reach Across VA, Department of Defense and Other Federal Healthcare Systems